have signed a definitive agreement to acquire Lonza Specialty Ingredients for a total enterprise value of CHF 4.2 billion
Trumont International serves as buy-side advisor to Cinven and Bain Capital on the acquisition of Lonza AG's Specialty Ingredients Division (Switzerland)
Bain Capital Private Equity ("Bain Capital") and Cinven (together "the consortium") have entered into definitive agreements to acquire Lonza Specialty Ingredients ("LSI"), a division of Lonza AG, for a total enterprise value of CHF 4.2 billion. The transaction is expected to close in H2 2021, subject to customary closing conditions.
LSI is a world-leading provider of specialty chemicals for microbial control solutions, used to eliminate or control harmful and unwanted micro-organisms. LSI's products are critical ingredients in disinfectants, preservatives, sanitizers, personal care products, as well as coatings and other industrial uses. The business also produces a range of other specialty chemicals, centred around its unique production facility in Switzerland.
Headquartered in Basel, Switzerland, LSI has approximately 2,800 employees, 11 R&D centres and 17 manufacturing sites across the world. The business serves circa 5,300 customers across a wide range of end-markets.
February 8, 2021